2018年11月26日星期一

95TiP Peptide vaccination against PD-L1 in multiple myeloma: A phase I trial

95TiP Peptide vaccination against PD-L1 in multiple myeloma: A phase I trial

NG Jørgensen, SM Ahmad, MT Lundsager… - Annals of …, 2017 - academic.oup.com
Background: The role of immunotherapy in multiple myeloma is well established–from the
use of thalidomide and its analogs over the recent approval of anti-CD38-and anti-SLAMF7-
antibodies to ongoing trials involving checkpoint blocking antibodies. The checkpoint …


For custom peptides, please visit www.pepmic.com. Our peptide services including but not limited to:
*Peptide Synthesis: From short peptides to long peptides, linear peptides to cyclic peptides.
*Peptide Modifications: Peptide-protein conjugation, D-amino acid peptides, isotope peptides, fluorescent peptides, multiple antigen peptides, multiple disulfide bridge peptides, phosphopeptides etc.
*Catalog Peptides: ACE Inhibitors, Amyloids & Related Peptides, Antimicrobial Peptides, Apelin Peptides, Myelin Oligodendrocyte Glycoprotein (MOG) Peptides, TAT Proteins etc.
*Peptide Salt: TFA, Desalt, Acetate, HCl.
*Peptide Purity: From crude to >99.5%.
*Production Capacity: From mg to kg, with a capacity of synthesizing 15,000 peptides/month.
*Peptide Library Synthesis: Alanine Scan, Overlapping, Positional Scan, T-cell Truncated, Scrambled ect.

Eva He
eva@pepmic.com
Pepmic Co., Ltd
www.pepmic.com


没有评论:

发表评论